Single and dual anastomosis duodenal switch for obesity treatment: a single-center experience

التفاصيل البيبلوغرافية
العنوان: Single and dual anastomosis duodenal switch for obesity treatment: a single-center experience
المؤلفون: Sofia S Pereira, Mariana P. Monteiro, Ana Marta Pereira, Rui Almeida, Marta Guimarães, Mário Nora
المصدر: Surgery for Obesity and Related Diseases. 17:12-19
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: medicine.medical_specialty, Sleeve gastrectomy, Duodenum, medicine.medical_treatment, 030209 endocrinology & metabolism, Type 2 diabetes, Anastomosis, Single Center, behavioral disciplines and activities, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Gastrectomy, Weight loss, Internal medicine, mental disorders, medicine, Humans, Obesity, Retrospective Studies, business.industry, Anastomosis, Surgical, Postoperative complication, Biliopancreatic Diversion, medicine.disease, Duodenal switch, Obesity, Morbid, Surgery, Diabetes Mellitus, Type 2, 030211 gastroenterology & hepatology, medicine.symptom, business, Dyslipidemia
الوصف: Background Biliopancreatic diversion with duodenal switch (BPD/DS) is the most effective bariatric surgery in super-obese patients, although technically complex and time consuming. As a primary surgery, single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is similar to BPD/DS in terms of short-term outcomes, but long-term and comparative data are lacking. Objectives The aim of this study was to compare the outcomes of patients submitted to SADI-S and BPD/DS. Setting Public hospital. Methods Obese patients (n = 112) submitted to SADI-S (n = 83) and BPD/DS (n = 29) for obesity treatment were prospectively compared. Results The mean preoperative body mass indexes (BMIs) were 53.41 ± .93 for BPD/DS and 50.61 ± .52 kg/m2 for SADI-S. Follow-up of 48 months was achieved in 18% (n = 21) of patients, with a nonsignificant difference in the percentage of excess BMI loss (%EBMIL; 81.20 ± 3.71 for BPD/DS; 74.82 ± 3.45 for SADI-S). Operative time (164.30 ± 7.78 minutes for BPD/DS; 132.70 ± 7.19 minutes for SADI-S; P = .006) and hospital stay (4.90 ± 1.10 days for BPD/DS; 4.35 ± .70 days for SADI-S; P = .006) were significantly shorter for SADI-S. There was no significant difference in the 30-day postoperative complication rate. No mortality was reported. After surgery, significant improvements were observed in glucose and lipid profiles for both groups. The type 2 diabetes remission rate was 100% for BPD/DS and ranged from 60 to 80% for SADI-S across follow-up times. Dyslipidemia remission followed a similar pattern. Protein deficiency was observed in up to 50% of patients after BPD/DS and 20% after SADI-S, without statistically significances. Conclusion SADI-S and BPD/DS as primary surgery for obesity treatment result in no significant differences in %EBMIL, improvement in obesity-related diseases, nutritional deficiencies, and postoperative morbidity. Nevertheless, there was greater total weight loss after BPD/DS. SADI-S, being less time consuming and technically simpler, can represent an advantage over BPD/DS.
تدمد: 1550-7289
DOI: 10.1016/j.soard.2020.09.029
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49773685b0cd1517907d62f281c9ef90
https://doi.org/10.1016/j.soard.2020.09.029
Rights: CLOSED
رقم الانضمام: edsair.doi.dedup.....49773685b0cd1517907d62f281c9ef90
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15507289
DOI:10.1016/j.soard.2020.09.029